Baxter Dextrose Injection Recall Over Stainless Steel Particulate Matter
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Baxter Healthcare Corporation is recalling 606 bags of Dextrose Injection, USP, 70% due to stainless steel particles.
Reading this FDA recall beyond the headline
This notice was issued by FDA on September 22, 2026 and geographically references United States. The FDA classifies this as a Class I recall, with the stated reason "Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.", distributed u.s. nationwide.. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Baxter Healthcare Corporation initiated a voluntary recall of Dextrose Injection, USP, 70% after particulate matter identified as stainless steel particles was found in the solution.
Which Products Are Affected
The recall involves Dextrose Injection, USP, 70%, 2000 mL bags, Rx Only, NDC 00338-0719-06, Lot #: Y495066, Exp. Date July 31, 2027. A total of 606 bags were distributed U.S. Nationwide.
What You Should Do
Consumers and healthcare providers should not use the affected product and should contact Baxter Healthcare Corporation regarding the recall.
Why This Matters
This Class I recall involves a drug product distributed nationwide that may contain stainless steel particles.
Source
FDA recall number D-0850-2026, report date 20260916.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Getinge PVC Thoracic Catheters Recall Over Bacterial Endotoxin Testing (Aug 7, 2026)
FDA · September 22, 2026
C.R. Bard Foley Catheter Trays Recall Over Pericare Wipes Contamination (Jun 25, 2026)
FDA · September 22, 2026
Given Imaging Bravo CF Capsule Delivery Device Recall Over Detachment Risk
FDA · September 22, 2026
Nationwide notices with similar length or severity timing 8
Two cross-category peer sets, both computed from Areazine's own archive: notices with a similar body length, and notices near the same severity and agency date. These are drawn from other categories, not the same-feed Related list above.
Similar body length
Nearest notices by article body length (779 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to September 22, 2026.
What People Ask
Common questions about this FDA recall.